BioSpace News Archive

IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the third quarter and the nine months ended April 30, 2023.

RAPT Therapeutics, Inc. today announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference.

Foghorn ® Therapeutics Inc. today announced management’s participation in the following investor conferences in June 2023.

eFFECTOR Therapeutics, Inc. today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of an aggregate of 7,764,445 shares of its common stock.

Inari Medical, Inc. announced the launch of two new purpose-built products, the RevCore thrombectomy catheter, and the Triever16 Curve catheter.

89bio, Inc. today announced that pegozafermin data in nonalcoholic steatohepatitis (NASH) will be featured in a late-breaker oral presentation during the European Association for the Study of the Liver (EASL) Congress 2023 to be held June 21-24, 2023 in Vienna.

Immutep Limited today announces Marc Voigt, CEO of Immutep, will be presenting at the Jefferies Healthcare Conference being held on June 7-9, 2023 in New York City, NY.

BeyondSpring Inc. today announced new data from a Phase 1 investigator initiated study highlighting a reduction in chemotherapy-induced infectious neutropenic fever with lead asset Plinabulin in combination with pegfilgrastim in multiple myeloma (MM) patients who underwent autologous hematopoietic stem cell transplantation (AHCT) and received a high dose of melphalan, a type of chemotherapy and one of the most active treatments for MM (NCT05130827).

The placenta, critical for healthy embryo development, is a multi-purpose organ with a precise lifespan—the length of a pregnancy.

Lipocine Inc. today announced that it will present posters on LPCN 1148 and LPCN 1144 at the forthcoming European Association for the Study of the Liver (EASL) Congress 2023, to take place in Vienna, Austria, June 21 – 24, 2023.